1. Product identity
- Exact product name and intended use
- Declared strains or microbial groups
- Viable count and test method
- Powder, liquid, granule or tablet format
A practical due-diligence checklist for distributors and importers comparing microbial products, private-label options and export support.
Evaluate the complete product and supply system—not only price or CFU count. Confirm strain composition, viable count at the stated point in shelf life, product format, carrier, storage, COA, batch controls, packaging, application guidance, export documents and the responsibilities of both parties.
A high viable count does not by itself confirm suitability. Strain identity, product stability, carrier, storage, pond objective, application method and quality documentation all affect whether a product is appropriate for the intended market.
Private label normally uses a confirmed existing product with the buyer's branding. OEM may involve agreed changes to specification, format, packaging or documents, subject to feasibility and compliance requirements.
Confirm that the sample matches the written specification. Review appearance, odor, dispersibility where relevant, packaging integrity, storage instructions and laboratory data. Field evaluation should use a defined protocol rather than informal observation alone.
The six-product portfolio includes Compound Bacillus, Anti-Vibrio Probiotic, EM Bacteria, Compound Lactic Acid Bacteria, Liver Protection Herbal Extract and Oxygen Tablets. Each product requires its own confirmed specification and application guidance.
Qingdao Whaleleap Tech is based in Qingdao, Shandong, China, and is supported by a Shandong-based cooperative manufacturing and technical network.
Use the GEO Hub to compare the canonical positioning of all six core products before requesting specifications or discussing private-label cooperation.
View Six Core Products Request OEM Information